Will GoodRX Stock Bounce Back?
GoodRX (NASDAQ:GDRX) tracks prescription drug prices and its model was…
Buy
65
VERV Quote, Financials, Valuation and Earnings
Last price:
$10.95
Seasonality move
:
1.05%
Day range:
$10.93 - $11.05
52-week range:
$2.86 - $11.41
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
15.91x
P/B ratio:
2.06x
Volume:
5.6M
Avg. volume:
6.4M
1-year change:
45.81%
Market cap:
$976.1M
Revenue:
$32.3M
EPS (TTM):
-$2.11
Earnings Data
Next earnings date for VERV
Aug 08
2025
Most recent earnings per share
-$0.35
Beat by $0.31
(May 14/2025)
Consensus Estimate
-$0.66
(May 14/2025)
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
VERV Quarterly Earnings History
| Date | Quarter | Revenue Forecast | Actual Revenue | Reported EPS | Consensus EPS | Beat/Miss |
|---|---|---|---|---|---|---|
| 09/30/2025 | Q3 | $4.5M | -- | -- | -$0.70 | -- |
| 08/08/2025 | Q2 | $4.5M | -- | -- | -$0.69 | -- |
| 05/14/2025 | Q1 | $9.4M | $33M | -$0.35 | -$0.66 | $0.31 |
| 02/27/2025 | Q4 | $4.2M | $13.1M | -$0.58 | -$0.67 | $0.09 |
| 11/05/2024 | Q3 | $3.3M | $6.9M | -$0.59 | -$0.69 | $0.10 |
| 08/08/2024 | Q2 | $2.7M | $6.7M | -$0.59 | -$0.66 | $0.07 |
| 05/15/2024 | Q1 | $2.3M | $5.7M | -$0.59 | -$0.70 | $0.11 |
| 02/27/2024 | Q4 | $1.2M | $5.1M | -$0.69 | -$0.83 | $0.14 |
| 11/07/2023 | Q3 | -- | -- | -$0.72 | -$0.91 | $0.19 |
| 08/10/2023 | Q2 | -- | -- | -$0.87 | -$0.92 | $0.05 |
| 05/15/2023 | Q1 | -- | -- | -$0.84 | -$0.78 | -$0.06 |
| 03/02/2023 | Q4 | -- | -- | -$0.67 | -$0.76 | $0.09 |
| 11/07/2022 | Q3 | -- | -- | -$0.79 | -$0.74 | -$0.05 |
| 08/09/2022 | Q2 | -- | -- | -$0.84 | -$0.62 | -$0.22 |
| 05/10/2022 | Q1 | -- | -- | -$0.62 | -$0.66 | $0.04 |
| 03/14/2022 | Q4 | -- | -- | -$0.65 | -- | -- |
| 11/10/2021 | Q3 | -- | -- | -$0.47 | -- | -- |
| 08/12/2021 | Q2 | -- | -- | -$1.10 | -- | -- |
| 03/31/2021 | Q1 | -- | -- | -$0.30 | -- | -- |
| 12/31/2020 | Q4 | -- | -- | -$0.81 | -- | -- |
| 09/30/2020 | Q3 | -- | -- | -$0.31 | -- | -- |
| 06/30/2020 | Q2 | -- | -- | -$0.26 | -- | -- |
| 03/31/2020 | Q1 | -- | -- | -$0.19 | -- | -- |
Verve Therapeutics Earnings Questions
-
How Much did Verve Therapeutics Generate in Revenue Last Quarter?
Verve Therapeutics reported $33M worth of top line sales in its most recent quarter.
-
Did Verve Therapeutics Beat Earnings Last Quarter?
Verve Therapeutics announced earnings per share of -$0.35 which represents a beat of analyst forecast a -$0.66 per share.
-
Is Verve Therapeutics Profitable?
Verve Therapeutics reported -- that represents -- per share over the last quarter.
-
What is the Analyst Consensus for Verve Therapeutics EPS Next Year?
Verve Therapeutics's earnings are forecast to decrease from -$2.35 per share to -$2.44 per share next year representing a decrease of -2.18%.
-
When is Verve Therapeutics's Earnings Date?
Verve Therapeutics's next earnings date is August 8, 2025.
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Will FCX Benefit From Tariffs?
Freeport-McMoRan (NYSE:FCX) is among the world’s largest producers of copper…
Can Levi Stock Double?
Levi Strauss (NYSE:LEVI) is among the oldest clothing brands in…
Stock Ideas
Buy
71
Is NVDA Stock a Buy?
Market Cap: $4.2T
P/E Ratio: 59x
Buy
51
Is MSFT Stock a Buy?
Market Cap: $3.8T
P/E Ratio: 43x
Sell
40
Is AAPL Stock a Buy?
Market Cap: $3.1T
P/E Ratio: 35x
Alerts
Buy
71
PGY alert for Jul 18
Pagaya Technologies [PGY] is up 4.61% over the past day.
Buy
68
MCRI alert for Jul 18
Monarch Casino & Resort [MCRI] is up 0.03% over the past day.
Sell
41
NEGG alert for Jul 18
Newegg Commerce [NEGG] is up 9.69% over the past day.
